…significantly improved among active treatment groups compared to placebo. ASDAS, a disease activity measure for axSpA, was also significantly improved among the active treatment arms compared to placebo at weeks…
…1.1 6.1) for celecoxib 400 mg per day compared to placebo and 3.4 (95% CI 1.5 7.9) for celecoxib 800 mg per day compared to placebo. In the PreSAP trial,…
Adalimumab (Humira) in Combination with Methotrexate is Efficacious for Treatment in RA Patients Weinblatt et al (Arthritis Rheum 48:35, 2003)) evaluate the efficacy and safety of adalimumab in combination with…
Inflimab, In Combination with Methotrexate, is Indicated for Inhibition of Progression of Structural Damage in RA Patients Infliximab (Remicade®), in combination with methotrexate, is now indicated for reducing signs and…
…1.1 6.1) for celecoxib 400 mg per day compared to placebo and 3.4 (95% CI 1.5 7.9) for celecoxib 800 mg per day compared to placebo. In the PreSAP trial,…
…leflunomide, 10-20 mg/day. Patients were evaluated for adverse effects as well as clinical responses using the ACR 20 response criteria. Twenty-three patients completed 1 year of treatment. The combination therapy…
